2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol

C25H25N9O — CID 170628271

IUPAC2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol
SMILESCn1ccnc1C#Cc1nccc(N2CCCN(c3cc(-c4ccccc4O)nnc3N)CC2)n1
InChIInChI=1S/C25H25N9O/c1-32-14-11-28-23(32)8-7-22-27-10-9-24(29-22)34-13-4-12-33(15-16-34)20-17-19(30-31-25(20)26)18-5-2-3-6-21(18)35/h2-3,5-6,9-11,14,17,35H,4,12-13,15-16H2,1H3,(H2,26,31)
InChIKeyAZPLDOXXFVECDS-UHFFFAOYSA-N
MW467.54 g/mol
LogP2.07
Rot. Bonds3

About 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol

2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol (PubChem CID 170628271) has the molecular formula C25H25N9O and a molecular weight of 467.54 g/mol. Its IUPAC name is 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol.

Molecular Properties

Compound Name2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol
PubChem CID170628271
Molecular FormulaC25H25N9O
Molecular Weight467.54 g/mol
Exact Mass467.22
IUPAC Name2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol
SMILESCn1ccnc1C#Cc1nccc(N2CCCN(c3cc(-c4ccccc4O)nnc3N)CC2)n1
InChIInChI=1S/C25H25N9O/c1-32-14-11-28-23(32)8-7-22-27-10-9-24(29-22)34-13-4-12-33(15-16-34)20-17-19(30-31-25(20)26)18-5-2-3-6-21(18)35/h2-3,5-6,9-11,14,17,35H,4,12-13,15-16H2,1H3,(H2,26,31)
InChIKeyAZPLDOXXFVECDS-UHFFFAOYSA-N
XLogP2.07
TPSA122.11 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds3
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500467.54
LogP ≤ 52.07
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol?
The IUPAC name of 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol (CID 170628271) is 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol.
What is the SMILES notation for 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol?
The canonical SMILES for 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol is Cn1ccnc1C#Cc1nccc(N2CCCN(c3cc(-c4ccccc4O)nnc3N)CC2)n1.
What is the InChIKey of 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol?
The InChIKey is AZPLDOXXFVECDS-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H25N9O/c1-32-14-11-28-23(32)8-7-22-27-10-9-24(29-22)34-13-4-12-33(15-16-34)20-17-19(30-31-25(20)26)18-5-2-3-6-21(18)35/h2-3,5-6,9-11,14,17,35H,4,12-13,15-16H2,1H3,(H2,26,31).
What are the key properties of 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol?
2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol has a molecular weight of 467.54 g/mol, XLogP of 2.07, 3 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-amino-5-[4-[2-[2-(1-methylimidazol-2-yl)ethynyl]pyrimidin-4-yl]-1,4-diazepan-1-yl]pyridazin-3-yl]phenol is sourced from PubChem (CID 170628271), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).